title: Need for improved treatment of postoperative pain.
abstract: BACKGROUND
  A cross-sectional study was performed at Rigshospitalet, Copenhagen, a Danish tertiary university hospital, to describe current postoperative pain and nausea treatment with a view to identifying areas with improvement potential.
  
  
  METHODS
  Data on up to four of the major and most frequent types of surgery were collected from each department based on interviews with the staff, audits of patient courses and electronic patient medication records. Staff guidelines on procedure-specific pain treatment were also collected.
  
  
  RESULTS
  Data on 121 patients from 12 surgical departments and 44 procedures were included in the study. No reliable information about the quality of pain management was available as no data on pain scores were detectable for the first three postoperative days (POD) for 55% (day 1), 71% (day 2) and 84% (day 3) of the patients. Most patients (75%) were treated with opioids. Non-opioid analgesic treatment was insufficient as the majority of patients did not receive sufficient 24-hour treatment with paracetamol and non-steroidal anti-inflammatory drugs, and only a minority received combination therapy. Nausea was found in approx. 20% on POD 1-3. Staff pain treatment guidelines were present in 14% of the cases.
  
  
  CONCLUSIONS
  Our results confirm that challenges exist in postoperative pain management as previously observed in multinational surveys. The way forward is procedure-specific treatment plans based on interdisciplinary collaboration implemented in conjunction with organizational changes. This work represents a natural extension of the work of the traditional acute pain clinic.
  
  
  BACKGROUND
  not relevant.
  
  
  BACKGROUND
  not relevant.
authors.affiliation: Section of Acute Pain Management and Palliative Care 4114, Rigshospitalet, Denmark. olemat@dadlnet.dk
authors.forename: Ole
authors.initials: O
authors.lastname: Mathiesen
authors.forename: Berit Ahlmann
authors.initials: BA
authors.lastname: Thomsen
authors.forename: Birgitte
authors.initials: B
authors.lastname: Kitter
authors.forename: Jørgen Berg
authors.initials: JB
authors.lastname: Dahl
authors.forename: Henrik
authors.initials: H
authors.lastname: Kehlet
mesh_terms: D000082:Acetaminophen / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D003718:Denmark; D005260:Female; D000077206:Gabapentin; D006301:Health Services Needs and Demand; D006801:Humans; D038622:Internationality; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010149:Postoperative Pain / Q000188:drug therapy* / Q000517:prevention & control; D020250:Postoperative Nausea and Vomiting / Q000188:drug therapy* / Q000517:prevention & control; D011787:Quality of Health Care / Q000592:standards / Q000706:statistics & numerical data*; D055815:Young Adult; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
chemical_list: D000588:Amines; D000700:Analgesics; D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003509:Cyclohexanecarboxylic Acids; D000082:Acetaminophen; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin